These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 25394070)

  • 41. Can we stop AIDS with antiretroviral-based treatment as prevention?
    Mills EJ; Nachega JB; Ford N
    Glob Health Sci Pract; 2013 Mar; 1(1):29-34. PubMed ID: 25276515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The aspirational necessity of HIV prevention.
    Corey L; Gray GE; Buchbinder SP
    J Int AIDS Soc; 2019 May; 22(5):e25289. PubMed ID: 31099956
    [No Abstract]   [Full Text] [Related]  

  • 43. Combination HIV prevention among MSM in South Africa: results from agent-based modeling.
    Brookmeyer R; Boren D; Baral SD; Bekker LG; Phaswana-Mafuya N; Beyrer C; Sullivan PS
    PLoS One; 2014; 9(11):e112668. PubMed ID: 25398143
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Female Condom Use and Adoption Among Men and Women in a General Low-Income Urban U.S. Population.
    Weeks MR; Zhan W; Li J; Hilario H; Abbott M; Medina Z
    AIDS Behav; 2015 Sep; 19(9):1642-54. PubMed ID: 25840799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two years of Truvada for pre-exposure prophylaxis utilization in the US.
    Flash C; Landovitz R; Giler RM; Ng L; Magnuson D; Wooley SB; Rawlings K
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19730. PubMed ID: 25397476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changing Knowledge and Attitudes Towards HIV Treatment-as-Prevention and "Undetectable = Untransmittable": A Systematic Review.
    Bor J; Fischer C; Modi M; Richman B; Kinker C; King R; Calabrese SK; Mokhele I; Sineke T; Zuma T; Rosen S; Bärnighausen T; Mayer KH; Onoya D
    AIDS Behav; 2021 Dec; 25(12):4209-4224. PubMed ID: 34036459
    [TBL] [Abstract][Full Text] [Related]  

  • 47. "Now that PrEP is reducing the risk of transmission of HIV, why then do you still insist that we use condoms?" the condom quandary among PrEP users and health care providers in Kenya.
    Irungu EM; Ngure K; Mugwanya KK; Awuor M; Dollah A; Ongolly F; Mugo N; Bukusi E; Wamoni E; Odoyo J; Morton JF; Barnabee G; Mukui I; Baeten JM; O'Malley G;
    AIDS Care; 2021 Jan; 33(1):92-100. PubMed ID: 32207327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The landscape for HIV pre-exposure prophylaxis during pregnancy and breastfeeding in Malawi and Zambia: A qualitative study.
    Zimba C; Maman S; Rosenberg NE; Mutale W; Mweemba O; Dunda W; Phanga T; Chibwe KF; Matenga T; Freeborn K; Schrubbe L; Vwalika B; Chi BH
    PLoS One; 2019; 14(10):e0223487. PubMed ID: 31584987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Understanding user perspectives of and preferences for oral PrEP for HIV prevention in the context of intervention scale-up: a synthesis of evidence from sub-Saharan Africa.
    Eakle R; Weatherburn P; Bourne A
    J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25306. PubMed ID: 31328429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1 serodiscordant couples in East Africa: a qualitative evaluation study in Uganda.
    Ware NC; Pisarski EE; Nakku-Joloba E; Wyatt MA; Muwonge TR; Turyameeba B; Asiimwe SB; Heffron RA; Baeten JM; Celum CL; Katabira ET
    J Int AIDS Soc; 2018 May; 21(5):e25113. PubMed ID: 29851436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?].
    Supervie V
    Med Sci (Paris); 2013 Apr; 29(4):373-82. PubMed ID: 23621932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study.
    Fowler N; Arkell P; Abouyannis M; James C; Roberts L
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19563. PubMed ID: 25394070
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Attitudes of serodiscordant couples towards antiretroviral-based HIV prevention strategies in Kenya: a qualitative study.
    Fowler N; Arkell P; Abouyannis M; James C; Roberts L
    AIDS Patient Care STDS; 2015 Jan; 29(1):33-42. PubMed ID: 25375792
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 55. "I just believe there is a risk" understanding of undetectable equals untransmissible (U = U) among health providers and HIV-negative partners in serodiscordant relationships in Kenya.
    Ngure K; Ongolly F; Dolla A; Awour M; Mugwanya KK; Irungu E; Mugo N; Bukusi EA; Morton J; Odoyo J; Wamoni E; Barnabee G; Peebles K; O'Malley G; Baeten JM;
    J Int AIDS Soc; 2020 Mar; 23(3):e25466. PubMed ID: 32144888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.
    Mack N; Evens EM; Tolley EE; Brelsford K; Mackenzie C; Milford C; Smit JA; Kimani J
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19157. PubMed ID: 25224616
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.